









Markets
/
Stocks
/
nasdaq-phg
/

Koninklijke Philips NV

PHG

28.170USD

-0.030-0.11%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

26.78BMarket Cap

138.44P/E TTM



Koninklijke Philips NV

28.170

-0.030-0.11%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

48 / 207

Overall Ranking

167 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

28.650

Target Price

+1.60%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 19.49B.

Overvalued

The company’s latest PE is 152.79, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 58.95M shares, decreasing 12.90% quarter-over-quarter.

Held by Sarah Ketterer

Star Investor Sarah Ketterer holds 1.85M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.19.

Financial Health

Currency: USD Updated：2025-09-15

The company's current financial score is 7.01, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 4.31B, representing a year-over-year decrease of 4.14%, while its net profit experienced a year-over-year decrease of 107.37%.

Score

Industry at a Glance

Previous score

7.01

Change

1.29



Financials

5.92

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.72

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.91

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.42

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 3.60, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 150.19, which is -105.93% below the recent high of -8.90 and 121.93% above the recent low of -32.93.

Score

Industry at a Glance

Previous score

1.76

Change

0.02

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 48/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Koninklijke Philips NV is 28.65, with a high of 30.30 and a low of 27.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

28.650

Target Price

+1.60%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Koninklijke Philips NV

PHG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 9.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 28.66 and the support level at 26.43, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.86

Change

-0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.034

Neutral

RSI(14)

59.450

Neutral

STOCH(KDJ)(9,3,3)

76.375

Neutral

ATR(14)

0.353

High Vlolatility

CCI(14)

79.380

Neutral

Williams %R

28.318

Buy

TRIX(12,20)

0.222

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

28.280

Sell

MA10

27.913

Buy

MA20

27.798

Buy

MA50

26.548

Buy

MA100

25.179

Buy

MA200

25.529

Buy

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 6.20%, representing a quarter-over-quarter decrease of 5.20%. The largest institutional shareholder is Sarah Ketterer, holding a total of 1.85M shares, representing 0.19% of shares outstanding, with 14.94% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Fiduciary Management, Inc.

7.52M

+21.68%

Mondrian Investment Partners Ltd.

7.11M

-0.33%

Dimensional Fund Advisors, L.P.

4.40M

+2.47%

Fidelity Management & Research Company LLC

4.64M

-15.35%

Causeway Capital Management LLC

Star Investors

1.53M

-2.24%

Parametric Portfolio Associates LLC

1.73M

-0.53%

Brandes Investment Partners, L.P.

Star Investors

992.20K

+8.01%

Northern Trust Global Investments

1.38M

+1.36%

Envestnet Asset Management, Inc.

1.32M

-3.63%

Connor, Clark & Lunn Investment Management Ltd.

1.76M

-20.98%

Risk Assessment

Currency: USD Updated：2025-09-15

The company's beta value is 0.80. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.